Zur Kurzanzeige

2022-06-02Zeitschriftenartikel
SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022
dc.contributor.authorSievers, Claudia
dc.contributor.authorZacher, Benedikt
dc.contributor.authorUllrich, Alexander
dc.contributor.authorHuska, Matthew
dc.contributor.authorFuchs, Stephan
dc.contributor.authorBuda, Silke
dc.contributor.authorHaas, Walter
dc.contributor.authorDiercke, Michaela
dc.contributor.authoran der Heiden, Matthias
dc.contributor.authorKröger, Stefan
dc.date.accessioned2022-07-19T10:22:21Z
dc.date.available2022-07-19T10:22:21Z
dc.date.issued2022-06-02none
dc.identifier.other10.2807/1560-7917.ES.2022.27.22.2200396
dc.identifier.urihttp://edoc.rki.de/176904/9956
dc.description.abstractGerman national surveillance data analysis shows that hospitalisation odds associated with Omicron lineage BA.1 or BA.2 infections are up to 80% lower than with Delta infection, primarily in ≥ 35-year-olds. Hospitalised vaccinated Omicron cases’ proportions (2.3% for both lineages) seemed lower than those of the unvaccinated (4.4% for both lineages). Independent of vaccination status, the hospitalisation frequency among cases with Delta seemed nearly threefold higher (8.3%) than with Omicron (3.0% for both lineages), suggesting that Omicron inherently causes less severe disease.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.rights(CC BY 3.0 DE) Namensnennung 3.0 Deutschlandger
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/de/
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleSARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022none
dc.typearticle
dc.identifier.urnurn:nbn:de:0257-176904/9956-5
dc.type.versionpublishedVersionnone
local.edoc.container-titleEurosurveillancenone
local.edoc.container-issn1560-7917none
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.22.2200396#html_fulltextnone
local.edoc.container-publisher-nameEuropean Centre for Disease Prevention and Controlnone
local.edoc.container-volume27none
local.edoc.container-issue22none
local.edoc.container-year2022none
dc.description.versionPeer Reviewednone

Zur Kurzanzeige